Pharmacy Report Archives - Page 20 of 139 - Becker's Hospital Review

8 drugs in shortage | AHA challenges J&J's 340B rebate plan | 1.5M ADHD drug bottles recalled | 10 best, worst states for women | NJ system enters specialty pharmacy partnership

March 5, 2025 BHR Newsletter 1. Healthcare groups push back against J&J rebate model Full story 2. Drugmaker recalls 1.5M bottles of generic ADHD medication Full story 3. 8 drugs now in shortage Full story 4. AI eliminated OR inefficiencies…

Pharmacy residents sue ASHP, 11 hospitals | 8 pharmacy cost-saving strategies | Tariffs take effect: 7 notes | FDA warnings for testosterone products | Fla. asks PBMs for patient data

March 4, 2025 BHR Newsletter 1. Pharmacy residents sue 11 hospitals, ASHP over alleged wage fixing Full story 2. FDA issues class-wide labeling changes to testosterone products Full story 3. Tariffs take effect: 7 notes Full story 4. AI is…

8 pharmacy cost-saving strategies | FDA warnings for testosterone products | UPMC ties losses to pharma | 10 best, worst states for women | PE deal could cause 3-way Walgreens split

March 3, 2025 BHR Newsletter 1. FDA issues class-wide labeling changes to testosterone products Full story 2. The top strategies pharmacy leaders use to maximize cost savings Full story 3. Lawmakers renew focus on PBMs: 4 things to know Full…

How Banner Health's GPO drives savings | More hospital pharmacies adopt RFID | 10 systems seeking pharmacy leaders | Christus to lay off 479 | Providence 1st to offer Pluvicto in Alaska

February 27, 2025 BHR Newsletter 1. How Banner Health's GPO is reshaping cost savings Full story 2. Hospital pharmacies tap into radio frequency tech Full story 3. Compounding pharmacies sue over Wegovy's removal from shortage list Full story 4. 7…

FDA loosens clozapine rule | Walgreens reaches $595M settlement | Eli Lilly offers cheaper Zepbound — again | UVA Health CEO resigns | After town's last pharmacy closes, Ohio system opens another

February 26, 2025 BHR Newsletter 1. Walgreens to pay $595M settlement in COVID-19 testing contract dispute Full story 2. FDA loosens rule, expands access for schizophrenia treatment Full story 3. Eli Lilly unveils high-dose, low-cost Zepbound vials Full story 4. Stagnant,…

Pharmacists to protest in 2 states | Orlando Health triples pharmacy space | 10 hardest-working US cities | Texas system to close 3 pharmacies | Rx platform exec pleads guilty in $1B scheme

February 25, 2025 BHR Newsletter 1. U of California pharmacists plan 3-day strike Full story 2. Orlando Health hospital expands inpatient pharmacy Full story 3. Alabama pharmacists to stage walkout over PBM bill Full story 4. From colorectal cancer to…

CommonSpirit CPO joins Mich. system | Wegovy copycats face deadline | Trump, pharma's clash: 4 notes | Fla. system to lay off 900+ | Label error spurs medication recall

February 24, 2025 BHR Newsletter 1. Michigan Medicine hires CPO from CommonSpirit Full story 2. Trump administration, pharma clash: 4 notes Full story 3. FDA sets deadline to end sales of Ozempic, Wegovy copycats Full story 4. Hospitals are feeling the…

FDA OKs generic chemotherapy for 2026 | Pa. hospital moves pharmacy to lobby | 10 systems seeking pharmacy leaders | 19-year CAR-T remission breaks record | CHS to sell 4 hospitals

February 20, 2025 BHR Newsletter 1. FDA approves generic cancer treatment for 2026 availability Full story 2. Pennsylvania system shifts outpatient pharmacy to hospital lobby Full story 3. Baxter IV plant restores pre-hurricane production Full story 4. Health IT leaders…

Merck jury trial delayed | Cleveland Clinic taps AI for drug repurposing | New pharmacy school opening in Neb. | Generics safety varies by maker: Study | Walgreens PE deal revived

February 19, 2025 BHR Newsletter 1. AI helps Cleveland Clinic uncover new uses for existing drugs Full story 2. Walgreens private equity deal 'alive' again: Report Full story 3. Jury trial over Merck vaccine delayed Full story 4. Technician workforces are shrinking…

HHS to probe some medicines | Pharmacy leaders seeking promotions: 2 tips | 1st rapid-acting insulin biosimilar approved | Hospital drug expenses rising | EHRs receive makeover

February 18, 2025 BHR Newsletter 1. FDA OKs 1st rapid-acting insulin biosimilar Full story 2. Pharmacy leaders seeking higher roles: 2 skills to hone Full story 3. CVS names PBM president Full story 4. Healthcare equipment downtime isn't an option…